Talk about circle jerks. The Eckgars, Vorlon, jz, electrifie,HH,Darrell and Darrell will go down as the biggest circle jerk in guiness book of records. What legitimacy has this company produced? A ph1 in liver that's 5 years old. A ph3 that is three+ years late.
I view these bond holders converting as the first step to clean up the books, so this can be acquired. They also now see the ownership of shares as a bigger opportunity then getting interest. Things behind the scenes are shaping up.
How the bashers all jump on the same bandwagon. That somehow the convertible bond players are selling. They haven't even got those shares yet. At least do some DD and look professional bashers. The markets were down yesterday. All these bashers want is a cheap shot at shares here. They understand t6he potential. They just want to time this. They also understand that Vitamin D news could be the day they no longer can afford this stock.
Shirley you wish you were a dude. I have been the single long who has questioned Paul. In fact he hasn't replied to any post of mine in six months. Unlike you dickfours from 2009, I question Paul about everything.
I see a company that was undercapitalized. They tried to use the shares price to work out of the funding issues and shareholders didn't accommodate them. Paul/Clayton have to live with that. Littleman you dispute is with Clayton/Iron/Stalag/JN. Just because I see a glimmer of hope, you want to make me the fall guy for your stupidity. Sorry, I didn't tell you to buy shares. I didn't give Iron a big kiss on the lips. I just own 1.335M shares. This is still America and I have the right to hold out hope. I may dislike what Clayton did. This may have been a whole different story if they had $2M in the bank. But you knew they were broke. Only a moron, would not know that they were undercapitalized.
Today I follow the IQD news and just maybe something falls in our lap. But somehow you and Vmax/badd all think that we are different than you. We are just you, you go have that operation, have then sew on a pair and standup and be a man. Because dude all I see is a crybaby. Stalag can lose on two RTO's, he can tell us that he knew JN's past and ignored it. But somehow this is our fault, because we hope they find funding. Dude, they needed funding four years ago. Nothing has change for me.
The study that PVCT has OUTLINED is flawed. The landscape in melanoma has so radically changed and where is this company, finally moving into a ph3 after 4 years of showing nothing concrete. The problem here is that they haven't told us everything. Had Eric opened up like he did the first time, this stock would never have gotten above .25. In biotech selling the sizzle will catch up with retail investors sooner than later. The first hint of dilution will nail the coffin here. Those lawsuits will cost the company, they cannot win them. This was a clever ruse and someone made a bundle. Four years shot. That saids it all.
This is what a real drug does for melanoma patients:
Reuters) - A late stage trial testing Bristol-Myers Squibb Co's cancer immunotherapy nivolumab in advanced melanoma patients was halted early after it was determined that the drug was likely to prolong survival, the company said on Tuesday.
The 418-patient Phase III study, called CheckMate -066, was testing nivolumab as an initial, or first line, therapy for patients with advanced melanoma, the deadliest form of skin cancer.
An interim analysis performed by an independent data monitoring committee found evidence of superior overall survival in patients receiving nivolumab compared with those who received the chemotherapy dacarbazine, Bristol said. The committee stopped the study early to allow the dacarbazine patients to switch to the Bristol drug.
Nivolumab belongs to a new class of medicines called PD-1 inhibitors that have generated great excitement for their ability to help the immune system recognize and attack cancer.
Analysts have forecast multibillion-dollar sales for the drugs being developed by several companies once they gain regulatory approval.
"The outcome of CheckMate -066 ... represents the first well-controlled, randomized Phase III trial of an investigational PD-1 checkpoint inhibitor to demonstrate an overall survival benefit," Michael Giordano, Bristol's head of oncology development, said in a statement.
Maybe they will squeeze out a BTD-AA. A $30B valuation. A china partnership on 8 patients in a ph1 liver trial. A abstract from AACR/ASCO?
I post about the volume yesterday and that is insider info. Take you head out of your rearend. You fools from 2010 are a trip. You lie everyday in 2009/2010 and when you lose, you blame others. Best part is that you carry a hard on for 5 years. You lose your sex change money? Thought you could make enough to maybe add another 3 inches. Shirley tempelariat....you wanted to say don't call me Shirley.
You are scared and stupid. Me going away is not going to change the matrix here. This company is in serious trouble. You and Hh will not be able to afford that hinny dissection. You will go through life too stupid to hit send at 9:30am and you know what, you deserved to get spanked here. You were dishonest using multiple Id's to pump a worthless stock. Just be thankful I didn't sell at $3.50 range, you would be my _itch.
I didn't know the facts. Neither do you. This company is very poorly managed. You are down to a ph3 which now looks like, will never get off the ground. Stock promoters and pump artists. This is looking real bad right now. This company is in some serious trouble. The lawsuits will drain them and almost indefensible. Like playing the Packers next year. Maybe you are in denial, but the street will shoot and ask questions later. I think it's safer to be on the sidelines and if they finally produce something real, then I will take another look.
Everything you believed is falling apart. This is why biotech's love retail investors. Not one actual thing has this company produced. They played you. Everyday is another bad surprise.
Amazing how the pumpers all come down with the same line. "Squeeze on". The pumpers know they are in some serious problems. Lawsuits piling on. No chance of any approval for 3 years. Bet the insiders never pay back the $2M they each owe. The only thing being squeezed is you're NUTS.
Actually I bought at $3.50 sold at $5.04. Bought at $1.58 sold at $2.28 Bought at $2.18 and sold at .90. Made .96 a share. I dropped my guard. Knew deep down you smucks were amateurs and greed lured me in.
Glad you admitted finally you got fooled. Like any good con, they feed on your greed and I'm human. I raised all the important issues and wanted to believe RB worked. Note to myself, if one cockroach with management decisions, more just hiding.
Your welcome. Nice doing business with such naïve investors. In the end you knew absolute nothing that was true about this drug. You took small amount of info and kept building g it bigger than it was. Now all that's left is that grand drop of the reality this is over. The shorts will dust you.
I did sell. Buy all you want it's your funeral. I believe AF single handed saved investors $2B nightmare. Insiders were preparing to exit stage right and maybe got caught with their hand in the cookie jar.
He's the only one you can trust. Company has done too many unethical things over the YEARS. I wish everyone the best and those pumpers, I hope you get it handed to you. Onto better plays. Made a few pennies a share. My only regret is not selling at $3.50 range and having JZ as my personal hand puppet. But time will tell. This is why you trade these early and get zero basis. This way you can balance your decisions.